Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Denali Therapeutics Inc. | COFO and Secretary | Common Stock | 524K | $356K | $0.68 | Nov 22, 2024 | Indirect |
Denali Therapeutics Inc. | COFO and Secretary | Common Stock | 199K | $135K | $0.68 | Nov 22, 2024 | Direct |
Denali Therapeutics Inc. | COFO and Secretary | Stock Option (right to buy) | 125K | Nov 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DNLI | Denali Therapeutics Inc. | Nov 22, 2024 | 2 | $14K | 4 | Nov 26, 2024 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Nov 7, 2024 | 5 | -$383K | 4 | Nov 12, 2024 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Aug 20, 2024 | 3 | -$200K | 4 | Aug 22, 2024 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Aug 13, 2024 | 1 | -$52K | 4 | Aug 15, 2024 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Feb 13, 2024 | 2 | -$402K | 4 | Feb 15, 2024 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Feb 8, 2024 | 2 | $34K | 4 | Feb 12, 2024 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Jan 5, 2024 | 1 | -$194K | 4 | Jan 9, 2024 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Jan 3, 2024 | 2 | $0 | 4 | Jan 5, 2024 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Aug 23, 2023 | 1 | -$58.4K | 4 | Aug 25, 2023 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Aug 21, 2023 | 1 | -$56K | 4 | Aug 23, 2023 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Aug 14, 2023 | 1 | -$65.6K | 4 | Aug 16, 2023 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Aug 10, 2023 | 1 | -$69K | 4 | Aug 14, 2023 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Jul 17, 2023 | 4 | -$534K | 4 | Jul 19, 2023 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | May 15, 2023 | 4 | -$233K | 4 | May 17, 2023 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Apr 12, 2023 | 6 | -$198K | 4 | Apr 14, 2023 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Feb 13, 2023 | 3 | -$88.2K | 4 | Feb 15, 2023 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Feb 8, 2023 | 1 | -$47K | 4 | Feb 10, 2023 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Jan 17, 2023 | 4 | -$243K | 4 | Jan 19, 2023 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Jan 5, 2023 | 1 | -$75K | 4 | Jan 9, 2023 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Jan 3, 2023 | 1 | -$83.6K | 4/A | Jan 9, 2023 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Oct 7, 2022 | 2 | $13.6K | 4 | Oct 12, 2022 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Aug 19, 2022 | 1 | -$85.6K | 4 | Aug 23, 2022 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Aug 9, 2022 | 1 | $0 | 4 | Aug 11, 2022 | COFO and Secretary |
DNLI | Denali Therapeutics Inc. | Feb 11, 2022 | 1 | -$97.2K | 4 | Feb 15, 2022 | COO and Secretary |
DNLI | Denali Therapeutics Inc. | Feb 9, 2022 | 1 | -$52.8K | 4 | Feb 11, 2022 | COO and Secretary |
DNLI | Denali Therapeutics Inc. | Jan 5, 2022 | 1 | -$127K | 4 | Jan 7, 2022 | COO and Secretary |
DNLI | Denali Therapeutics Inc. | Jan 3, 2022 | 2 | $0 | 4 | Jan 5, 2022 | COO and Secretary |
DNLI | Denali Therapeutics Inc. | Dec 6, 2021 | 2 | -$423K | 4 | Dec 8, 2021 | COO and Secretary |
DNLI | Denali Therapeutics Inc. | Nov 4, 2021 | 2 | -$528K | 4 | Nov 8, 2021 | COO and Secretary |
DNLI | Denali Therapeutics Inc. | Oct 4, 2021 | 2 | -$506K | 4 | Oct 6, 2021 | COO and Secretary |
DNLI | Denali Therapeutics Inc. | Sep 20, 2021 | 2 | $6.15K | 4 | Sep 22, 2021 | COO and Secretary |
DNLI | Denali Therapeutics Inc. | Sep 7, 2021 | 3 | -$555K | 4 | Sep 9, 2021 | COO and Secretary |
DNLI | Denali Therapeutics Inc. | Aug 19, 2021 | 2 | -$126K | 4 | Aug 23, 2021 | COO and Secretary |
DNLI | Denali Therapeutics Inc. | Aug 4, 2021 | 3 | -$522K | 4 | Aug 6, 2021 | COO and Secretary |
DNLI | Denali Therapeutics Inc. | Jul 6, 2021 | 1 | -$762K | 4 | Jul 8, 2021 | COO and Secretary |
DNLI | Denali Therapeutics Inc. | Jun 4, 2021 | 2 | -$645K | 4 | Jun 8, 2021 | COO and Secretary |